Adaptive Biotechnologies (ADPT) Operating Income Growth (3y) (2021 - 2026)
Adaptive Biotechnologies (ADPT) Operating Income Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 9.77% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -1.04% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 12.32% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 1.37% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -1.16% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 12.85% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 68.50% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 3.10% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 19.25% |
| 10 | Adaptive Biotechnologies | 4.23 Bn | 3.89 Bn | 51.39 Mn | 30.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.91% |
| Mar 31, 2026 | 30.49% |
| Dec 31, 2025 | 31.18% |
| Sep 30, 2025 | 30.58% |
| Jun 30, 2025 | 21.87% |
| Mar 31, 2025 | 22.28% |
| Dec 31, 2024 | 18.10% |
| Sep 30, 2024 | 16.64% |
| Jun 30, 2024 | 1.67% |
| Mar 31, 2024 | -5.71% |
| Dec 31, 2023 | -17.12% |
| Sep 30, 2023 | -11.21% |
| Jun 30, 2023 | -9.02% |
| Mar 31, 2023 | -18.21% |
| Dec 31, 2022 | -17.45% |
| Sep 30, 2022 | -36.02% |
| Jun 30, 2022 | -48.28% |
| Mar 31, 2022 | -46.53% |
| Dec 31, 2021 | -63.30% |
| Sep 30, 2021 | -83.20% |